1 / 32

Materials and methods

Materials and methods. Design Open-label, randomized trial, February 2010 to May 2011, avoiding the summer period Participants recruited from a primary care centre in Sweden , serving a population with a high proportion of non-European residents Inclusion criteria

lucky
Télécharger la présentation

Materials and methods

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Materials and methods • Design • Open-label, randomized trial, February 2010 to May 2011, avoiding the summer period • Participants • recruited from a primary care centre in Sweden, serving a population with a high proportion of non-European residents • Inclusion criteria • age 15 years or above and vitamin D deficiency 25(OH)D3 less than 25 nmol /L • Exclusion criteria • light-sensitive skin • ongoing treatment with vitamin D supplementation • sunny holidays • intake of photosensitive medicine during the study period.

  2. UVB • The average starting dose was 0.36 J • increments were about 15% every second treatment session • the average maximal (final) dose was 1.20 J. • The mean cumulative dose was 9.0 J /cm2

  3. Results • Significantly greater increase in 25(OH)D3 levels in the NB-UVB treated group compared with the tablet-treated group after 6 weeks of treatment (P = 0.02) • in the NB-UVB treated group The 25(OH)D3 levels (mean ± SD) increased from 19.2 ± 6 nmol/L to 75 ± 16.8 nmol/L vs. 23.3 ±4.4 nmol/L to 60.6 ± 16.7 nmol /L in the oral vitamin D3 treated group

  4. Results • No significant difference regarding PTH, calcium, albumin or HbA1c levels. • Asignificant decrease in PTH • A significant increase in calcium levels

  5. Limitations • lack of compliance among the group who took vitamin D3 supplements • high dropout number • primarily non-European immigrants

  6. Conclusion • exposure to a small dose of full body NB-UVB radiation three times a week is more efficient in raising vitamin D levels than prescription of a daily oral intake of 1600 IU vitamin D3

  7. Race ?Skin type ?

  8. Suscreen ?

  9. Winter vs summer

  10. NB UVB vs BB UVB ?

  11. Diet ?

  12. Screening ?

  13. Deficiency ?

  14. -Vitamin D deficiency is defined as a 25(OH)D below 20 ng/ml (50 nmol/liter)- Vitamin D insufficiency is defined as a 25(OH)D of 21–29 ng/ml

  15. Daily requirement ?

  16. Treatment

More Related